Trial Profile
A Phase II/III, randomized, double-blind, placebo-controlled trial to evaluate the safety and efficacy of atacicept in combination with corticosteroids and sequential therapy with cyclophosphamide and azathioprine in subjects with lupus nephritis.
Status:
Completed
Phase of Trial:
Phase II/III
Latest Information Update: 03 Aug 2011
Price :
$35
*
At a glance
- Drugs Atacicept (Primary) ; Azathioprine; Corticosteroids; Cyclophosphamide
- Indications Lupus nephritis
- Focus Therapeutic Use
- 03 Aug 2011 New trial record